These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 16848401)

  • 1. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.
    Sawant RM; Hurley JP; Salmaso S; Kale A; Tolcheva E; Levchenko TS; Torchilin VP
    Bioconjug Chem; 2006; 17(4):943-9. PubMed ID: 16848401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.
    Koren E; Apte A; Jani A; Torchilin VP
    J Control Release; 2012 Jun; 160(2):264-73. PubMed ID: 22182771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates.
    Kale AA; Torchilin VP
    Bioconjug Chem; 2007; 18(2):363-70. PubMed ID: 17309227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environment-responsive multifunctional liposomes.
    Kale AA; Torchilin VP
    Methods Mol Biol; 2010; 605():213-42. PubMed ID: 20072884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes.
    Kale AA; Torchilin VP
    J Liposome Res; 2007; 17(3-4):197-203. PubMed ID: 18027240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells.
    Sawant RR; Sawant RM; Kale AA; Torchilin VP
    J Drug Target; 2008 Aug; 16(7):596-600. PubMed ID: 18686130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
    Torchilin VP; Levchenko TS; Lukyanov AN; Khaw BA; Klibanov AL; Rammohan R; Samokhin GP; Whiteman KR
    Biochim Biophys Acta; 2001 Apr; 1511(2):397-411. PubMed ID: 11286983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.
    Biswas S; Dodwadkar NS; Sawant RR; Torchilin VP
    Bioconjug Chem; 2011 Oct; 22(10):2005-13. PubMed ID: 21870873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements.
    Koren E; Apte A; Sawant RR; Grunwald J; Torchilin VP
    Drug Deliv; 2011 Jul; 18(5):377-84. PubMed ID: 21438724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.
    Kale AA; Torchilin VP
    J Drug Target; 2007; 15(7-8):538-45. PubMed ID: 17671900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example.
    Sawant RR; Torchilin VP
    Methods Mol Biol; 2010; 624():131-49. PubMed ID: 20217593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
    Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
    Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micelles of enzymatically synthesized PEG-poly(amine-co-ester) block copolymers as pH-responsive nanocarriers for docetaxel delivery.
    Zhang X; Liu B; Yang Z; Zhang C; Li H; Luo X; Luo H; Gao D; Jiang Q; Liu J; Jiang Z
    Colloids Surf B Biointerfaces; 2014 Mar; 115():349-58. PubMed ID: 24398083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers.
    Kim JH; Li Y; Kim MS; Kang SW; Jeong JH; Lee DS
    Int J Pharm; 2012 May; 427(2):435-42. PubMed ID: 22342467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers.
    Salmaso S; Pappalardo JS; Sawant RR; Musacchio T; Rockwell K; Caliceti P; Torchilin VP
    Bioconjug Chem; 2009 Dec; 20(12):2348-55. PubMed ID: 19928843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo.
    Sawant RR; Torchilin VP
    Int J Pharm; 2009 Jun; 374(1-2):114-8. PubMed ID: 19446767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable pH-Sensitive Poly(ethylene glycol) Nanocarriers for Allergen Encapsulation and Controlled Release.
    Pohlit H; Bellinghausen I; Schömer M; Heydenreich B; Saloga J; Frey H
    Biomacromolecules; 2015 Oct; 16(10):3103-11. PubMed ID: 26324124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tatp-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):816-20. PubMed ID: 17635155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
    Torchilin VP
    Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.